Concepedia
Statistics
Publications
19
Citations
1.1K
H-Index
16
Active since
2013
Affiliations
Dana-Farber Cancer Institute(Current)
Harvard University
VA Boston Healthcare System
Inserm
Akdeniz University
Anıl Aktaş Samur is an author at Dana-Farber Cancer Institute specializing in multiple myeloma, life sciences, and medicine.
Publications per year
2013–2025
Biallelic loss of BCMA as a resistance mechanism to CAR T cell therapy in a patient with multiple myeloma
Mehmet Samur, Mariateresa Fulciniti, Anıl Aktaş Samur et al. · Nature Communications · 2021 · 409 citations · Full text
Life Sciences, Genetics, Molecular Biology +15
ILF2 Is a Regulator of RNA Splicing and DNA Damage Response in 1q21-Amplified Multiple Myeloma
Matteo Marchesini, Yamini Ogoti, Elena Fiorini et al. · Cancer Cell · 2017 · 163 citations · Full text
Life Sciences, Genetics, Molecular Biology +12
Genome-Wide Somatic Alterations in Multiple Myeloma Reveal a Superior Outcome Group
Mehmet Samur, Anıl Aktaş Samur, Mariateresa Fulciniti et al. · Journal of Clinical Oncology · 2020 · 78 citations · Full text
Medicine, Genetics, Oncology +17
Deciphering the chronology of copy number alterations in Multiple Myeloma
Anıl Aktaş Samur, Stéphane Minvielle, Masood A. Shammas et al. · Blood Cancer Journal · 2019 · 63 citations · Full text
Life Sciences, Genetics, Molecular Genetics +17
Long intergenic non-coding RNAs have an independent impact on survival in multiple myeloma
Mehmet Samur, Stéphane Minvielle, Annamaria Gullà et al. · Leukemia · 2018 · 56 citations · Full text
1–5 of 19